We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
1 result(s) found, displaying 1 to 1
-
Australian public assessment report (AusPar)Forxiga (dapagliflozin) was approved as an adjunct to diet and exercise in patients with type 2 diabetes mellitus for whom metformin is otherwise indicated but not tolerated. It was also approved as a combination therapy to be used with other drugs to improve glycaemic control.